Assessment of nalmefene glucuronide as a selective gut opioid antagonist
Open Access
- 31 August 1995
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 39 (2) , 151-154
- https://doi.org/10.1016/0376-8716(95)01153-p
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Oral naloxone in opioid-associated constipationThe Lancet, 1991
- Colon Motility in Opiate Addiction and Naloxone‐Precipitated WithdrawalNeurogastroenterology & Motility, 1990
- Idiopathic slow‐transit constipation: whole gut transit times, measured by a new simplified method, are not shortened by opioid antagonistsAlimentary Pharmacology & Therapeutics, 1987
- Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.Gut, 1985
- Patient perspectives of opiate withdrawalDrug and Alcohol Dependence, 1983
- Pharmacology of Antidiarrheal DrugsAnnual Review of Pharmacology and Toxicology, 1983
- Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β-hydroxylaseNeuroscience, 1980
- NALOXONE INHIBITS THE ANTI‐DIARRHOEAL ACTIVITY OF LOPERAMIDEBritish Journal of Pharmacology, 1979
- Naloxone Treatment of Opiate DependenceJAMA, 1971
- EFFECT OF MORPHINE AND DILAUDID ON THE ILEUM AND OF MORPHINE, DILAUDID AND ATROPINE ON THE COLON OF MANArchives of internal medicine (1960), 1942